Business · 12/07/2022Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of 31 Abbreviated New Drug Applications
Summary
The Food and Drug Administration has withdrawn approval of 31 abbreviated new drug applications from multiple applicants, following written notifications that the drug products were no longer in use.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →